Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.095 USD | -1.43% | +31.84% | +74.29% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.29% | 587M | |
+32.71% | 50.85B | |
+0.08% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.83% | 26.11B | |
-22.22% | 19.13B | |
+8.20% | 13.05B | |
+27.21% | 12.16B | |
+24.40% | 12.08B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Insider Buy: Taysha Gene Therapies